ClinConnect ClinConnect Logo
Search / Trial NCT06554067

Effects of tDCS and VNS on Postoperative Analgesia

Launched by COLUMBIA UNIVERSITY · Aug 12, 2024

Trial Information

Current as of August 21, 2025

Not yet recruiting

Keywords

Postoperative Pain Chronic Pain Transcranial Direct Current Stimulation Vagus Nerve Stimulation

ClinConnect Summary

This clinical trial is looking at two treatments, transcranial direct current stimulation (tDCS) and Afferent Vagus nerve stimulation (VNS), to see if they can help reduce pain after surgery. The study will involve adults who are having elective surgeries that require general anesthesia. Researchers will measure how much pain patients feel, along with other important health signs, and track how much pain medicine they need in the first 24 hours after surgery.

To participate, you need to be at least 18 years old and able to give consent. However, some people won’t be eligible, such as those with certain heart conditions, pregnant individuals, or those with a history of seizures. If you join the study, you will be placed in one of four groups, where you may receive either the active treatment, a fake version of the treatment, or both. This trial is not yet recruiting participants, so you'll want to keep an eye out for when it begins if you're interested.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults aged 18 years or above with the capacity to provide informed consent who are undergoing an elective surgery requiring general anesthesia
  • Exclusion Criteria:
  • cardiac bradyarrhythmia: taking beta-blockers;
  • patients with metal implants around the chest, neck, or head (e.g. implantable pacemakers and defibrillators, deep brain stimulation devices);
  • pregnancy
  • history of epilepsy or seizures.
  • patients undergoing surgical procedures involving the head, neck or spine, or those requiring the use of cardiopulmonary bypass

About Columbia University

Columbia University, a prestigious Ivy League institution located in New York City, is a leading sponsor of clinical trials dedicated to advancing medical research and improving patient care. With a robust network of research facilities and a commitment to innovation, Columbia University collaborates with a diverse range of healthcare professionals and researchers to explore groundbreaking therapies and treatment methodologies. The university's clinical trials encompass various fields, including oncology, neurology, and public health, aiming to translate scientific discoveries into effective clinical applications. Columbia University is dedicated to maintaining the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants while contributing to the global body of medical knowledge.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported